Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


19.11.2018

1 AJR Am J Roentgenol
1 Aliment Pharmacol Ther
2 Am J Gastroenterol
1 BMC Gastroenterol
1 Dig Dis
1 Dig Dis Sci
1 Gut
2 Inflamm Bowel Dis
6 J Crohns Colitis
1 PLoS One
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. KITAZUME Y, Fujioka T, Takenaka K, Oyama J, et al
    Crohn Disease: A 5-Point MR Enterocolonography Classification Using Enteroscopic Findings.
    AJR Am J Roentgenol. 2018 Nov 13:1-10. doi: 10.2214/AJR.17.18897.
    PubMed     Text format     Abstract available


    Aliment Pharmacol Ther

  2. NOURELDIN M, Higgins PDR, Govani SM, Cohen-Mekelburg S, et al
    Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids.
    Aliment Pharmacol Ther. 2018 Nov 14. doi: 10.1111/apt.15023.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  3. VERNERO M, Astegiano M, Ribaldone DG
    New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0422.
    PubMed     Text format    

  4. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Shen N, et al
    Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes.
    Am J Gastroenterol. 2018 Nov 12. pii: 10.1038/s41395-018-0417.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. PALLOTTA N, Vincoli G, Pezzotti P, Giovannone M, et al
    A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    BMC Gastroenterol. 2018;18:164.
    PubMed     Text format     Abstract available


    Dig Dis

  6. ZIADE F, Rungoe C, Kallemose T, Paerregaard A, et al
    Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.
    Dig Dis. 2018 Nov 13:1-7. doi: 10.1159/000494215.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. CHAPARRO M, Barreiro-de Acosta M, Echarri A, Almendros R, et al
    Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Nov 13. pii: 10.1007/s10620-018-5362.
    PubMed     Text format     Abstract available


    Gut

  8. UNGARO RC, Limketkai BN, Jensen CB, Allin KH, et al
    Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts.
    Gut. 2018 Nov 12. pii: gutjnl-2018-317021. doi: 10.1136/gutjnl-2018-317021.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  9. AHMED Z, Sarvepalli S, Garber A, Regueiro M, et al
    Value-Based Health Care in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 9. pii: 5168541. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. KELLY OB, Li N, Smith M, Chan J, et al
    The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Nov 14. pii: 5183322. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  11. WEN KW, Rabinovitch PS, Wang D, Huang D, et al
    Utility of DNA Flow Cytometric Analysis of Paraffin-Embedded Tissue in the Risk Stratification and Management of "Indefinite for Dysplasia" in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Nov 13. pii: 5180116. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. FIORINO G, Allocca M, Chaparro M, Coenen S, et al
    'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2018 Nov 13. pii: 5181323. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. AMBROSE T, Simmons A
    Cannabis, cannabinoids and the endocannabinoid system - is there therapeutic potential for inflammatory bowel disease?
    J Crohns Colitis. 2018 Nov 12. pii: 5173479. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. DE BRUYN JR, van den Brink GR, Steenkamer J, Buskens CJ, et al
    Fibrostenotic Phenotype of Myofibroblasts in Crohn's Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition.
    J Crohns Colitis. 2018;12:849-859.
    PubMed     Text format     Abstract available

  15. WARDLE RA, Thapaliya G, Nowak A, Radford S, et al
    An Examination of Appetite and Disordered Eating in Active Crohn's Disease.
    J Crohns Colitis. 2018;12:819-825.
    PubMed     Text format     Abstract available

  16. RISPO A, Imperatore N, Testa A, Bucci L, et al
    Combined Endoscopic/Sonographic-based Risk Matrix Model for Predicting One-year Risk of Surgery: A Prospective Observational Study of a Tertiary Centre Severe/Refractory Crohn's Disease Cohort.
    J Crohns Colitis. 2018;12:784-793.
    PubMed     Text format     Abstract available


    PLoS One

  17. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  18. STALLMACH A, Reuken PA, Teich N
    [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
    Z Gastroenterol. 2018;56:1369-1377.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: